ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has recommended a 38 percent reduction in the price of 100 mg Remdesivir injection, recommending its price to be kept not more than Rs5,680.
Sources said the federal government is likely to approve a major reduction in the price of Remdesivir injection used to treat COVID-19 patients. Sources further said a summary in this regard was sent to the federal cabinet by the health ministry.
As per the summary, DRAP has recommended the government to fix the price of 100mg Remdesivir injection at Rs5,680 following a decline in its rate in the international market.
Meanwhile, Special Assistant to the Prime Minister Dr Faisal Sultan in a press conference informed that the price of remdesivir, a drug used to treat coronavirus patients, has also been dropped. Govt has fixed price up to Rs 5000 for a Remdesivir injection he added.
Responding to a question regarding the World Health Organisation’s recent findings on remdesivir, he said that the body had issued a rule, however, had not stopped the usage of the drug.
Earlier, the federal cabinet had fixed its price at Rs10,873, which was then lowered to Rs9,244 by DRAP on August 17. As of now, the price of Remdesivir injection has fallen from $50 to $35 in the international market.